Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500μg vs Fluticasone Propionate 500μg in Patients with Corticosteroid-Dependent Asthma V: Results

被引：0

作者：

Willem R. Pieters

Bo Lundbäck

Seema Sondhi

Martin J. Price

Robert M.A. Thwaites

机构：

[1] Elkerliek Ziekenhuis,Respiratory Unit

[2] National Institute for Working Life,Global Health Outcomes

[3] Glaxo Wellcome,undefined

来源：

PharmacoEconomics | 1999年 / 16卷

关键词：

Asthma; Adis International Limited; Fluticasone Propionate; Salmeterol; Formoterol;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Methods: An economic analysis was performed to compare the cost effectiveness of a new formulation combining salmeterol 50μg and fluticasone propionate 500μg in a multidose dry powder (Diskus™) inhaler (n = 167) with that of fluticasone propionate (FP) 500μg (n = 165) also delivered via the Diskus™ in patients with corticosteroid-dependent asthma. Clinical data were obtained from a recent European multicentre trial; the economic analysis adopted a Swedish healthcare perspective.

引用

页码：29 / 34

页数：5

共 50 条

[1] Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/500μg vs fluticasone propionate 500μg in patients with corticosteroid-dependent asthma V:: Results
Pieters, WR
Lundbäck, B
Sondhi, S
Price, MJ
Thwaites, RMA
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 29 - 34
[2] Cost-effectiveness of fluticasone propionate/salmeterol (500/50 μg) in the treatment of COPD
Earnshaw, Stephanie R.
Wilson, Michele R.
Dalal, Anand A.
Chambers, Mike G.
Jhingran, Priti
Stanford, Richard
Mapel, Douglas W.
RESPIRATORY MEDICINE, 2009, 103 (01) : 12 - 21
[3] Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/100μg vs fluticasone propionate 100μg in adults and adolescents with asthma III:: Results
Johansson, G
Price, MJ
Sondhi, S
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 15 - 21
[4] Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/250μg vs fluticasone propionate 250μg in adults and adolescents with asthma IV:: Results
Palmqvist, M
Price, MJ
Sondhi, S
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 23 - 28
[5] Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/250μg vs Fluticasone Propionate 250μg in Adults and Adolescents with Asthma IV: Results
Mona Palmqvist
Martin J. Price
Seema Sondhi
PharmacoEconomics, 1999, 16 : 23 - 28
[6] Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100μg vs Fluticasone Propionate 100μg in Adults and Adolescents with Asthma III: Results
Gunnar Johansson
Martin J. Price
Seema Sondhi
PharmacoEconomics, 1999, 16 : 15 - 21
[7] Salmeterol/fluticasone propionate (50/250 μg) combination is superior to double dose fluticasone (500 μg) for the treatment of symptomatic moderate asthma
Bergmann, KC
Lindemann, L
Braun, R
Steinkamp, G
SWISS MEDICAL WEEKLY, 2004, 134 (3-4) : 50 - 58
[8] Improvements in asthma-specific quality of life in oral corticosteroid-dependent patients treated with fluticasone propionate powder 500μg or 1000μg
Mahajan, P
Metcalf, M
Okamoto, L
Wolford, J
Harding, S
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S7 - S7
[9] Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma I:: Introduction and overview
Lundbäck, B
Pieters, WR
Johansson, G
Palmqvist, M
Price, MJ
Sondhi, S
Thwaites, RMA
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 1 - 8
[10] Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma II:: Study methodologies
Pieters, WR
Lundbäck, B
Johansson, G
Palmqvist, M
Price, MJ
Sondhi, S
Thwaites, RMA
Yan, SK
PHARMACOECONOMICS, 1999, 16 (Suppl 2) : 9 - 14

← 1 2 3 4 5 →